Teen hosts podcast featuring peers with hyper IgM syndrome
New NAC members dedicated to solving the ‘puzzles’ of PI
Primary immunodeficiency can bring other immune system diagnoses
Volunteer established PI education groups 33 years ago
Ask the expert: PI and travel
Mavorixafor approved for treating WHIM syndrome
Insurers block immunoglobulin access using multiple tactics
Immunoglobulin product booklet
Xolremdi
Mavorixafor.
Approved to treat: Warts, hypogammaglobulinemia, immunodeficiency, myelokathexis (WHIM) syndrome.
Ages: 12+
Report side effects/adverse events at 1-866-MED-X4MI (1-866-633-9464).